Morgan Stanley’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Morgan Stanley’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$50	–	8002
2023 Q3	$50	Hold	1,000	–	–	﹤0.01%	7484
2023 Q2	$210	Hold	1,000	–	–	﹤0.01%	7451
2023 Q1	$160	Hold	1,000	–	–	﹤0.01%	7532
2022 Q4	$220	Hold	1,000	–	–	﹤0.01%	7637
2022 Q3	$3K	Hold	1,000	–	–	﹤0.01%	7419
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	7729
2022 Q1	$2K	Hold	1,000	–	–	﹤0.01%	7786
2021 Q4	$2K	Sell	1,000 -4,989	-83%	-$15.1K	﹤0.01%	7816
2021 Q3	$25K	Hold	5,989	–	–	﹤0.01%	7022
2021 Q2	$22K	Buy	+5,989	New	+$27K	﹤0.01%	6979

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley's CANO.WS Position: Q4 2023 in Review

Morgan Stanley sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 1,000 shares — an estimated $50 sold.

Morgan Stanley first reported a position in CANO.WS in Q2 2021 and held it in 10 quarters. The position peaked at $25K in Q3 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Morgan Stanley reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Morgan Stanley sold 1,000 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $50.
Morgan Stanley first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 10 quarters.
Morgan Stanley's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $25K in Q3 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.